Angiolillo, D. J., Firstenberg, M. S., Price, M. J., Tummala, P. E., Hutyra, M., Welsby, I. J., … Topol, E. J. (2011). The Safety and Efficacy Of Cangrelor, a Short Acting, Intravenous, Reversible, Platelet P2Y12 Inhibiror In Patients Awaiting Cardiac Surgery: Results Of the BRIDGE Trial. In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (Vol. 58, pp. XIII–XIII). San Francisco, CA: ELSEVIER SCIENCE INC.

Angiolillo, Dominick J., Michael S. Firstenberg, Matthew J. Price, Pradyumna E. Tummala, Martin Hutyra, Ian J. Welsby, Michele D. Voeltz, et al. “The Safety and Efficacy Of Cangrelor, a Short Acting, Intravenous, Reversible, Platelet P2Y12 Inhibiror In Patients Awaiting Cardiac Surgery: Results Of the BRIDGE Trial.” In JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 58:XIII–XIII. ELSEVIER SCIENCE INC, 2011.

Angiolillo DJ, Firstenberg MS, Price MJ, Tummala PE, Hutyra M, Welsby IJ, et al. The Safety and Efficacy Of Cangrelor, a Short Acting, Intravenous, Reversible, Platelet P2Y12 Inhibiror In Patients Awaiting Cardiac Surgery: Results Of the BRIDGE Trial. In: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2011. p. XIII–XIII.

Angiolillo, Dominick J., et al. “The Safety and Efficacy Of Cangrelor, a Short Acting, Intravenous, Reversible, Platelet P2Y12 Inhibiror In Patients Awaiting Cardiac Surgery: Results Of the BRIDGE Trial.” JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, vol. 58, no. 20, ELSEVIER SCIENCE INC, 2011, pp. XIII–XIII.

Angiolillo DJ, Firstenberg MS, Price MJ, Tummala PE, Hutyra M, Welsby IJ, Voeltz MD, Chandna H, Ramaiah C, Brtko M, Cannon L, Liu T, Prats J, Topol EJ. The Safety and Efficacy Of Cangrelor, a Short Acting, Intravenous, Reversible, Platelet P2Y12 Inhibiror In Patients Awaiting Cardiac Surgery: Results Of the BRIDGE Trial. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. ELSEVIER SCIENCE INC; 2011. p. XIII–XIII.